Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2. - Wikidata - wikimedia - TriplyDB

Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.

Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.

http://www.wikidata.org/entity/Q48455124

about

Pulmonary epithelial barrier function: some new players and mechanisms Human epidermal growth factor receptor signaling in acute lung injury MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.HER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeability Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs.Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy.The ERBB3 receptor in cancer and cancer gene therapy Airway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profile.Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis.EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.ERBB2-induced inflammation in lung carcinogenesis.A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset Bleomycin-Induced Lung Injury

P2860

Q26865861-1FA03617-8416-46EA-AC83-5FC97E3B3D93 Q27002075-FAFEF326-1903-4EAB-A7AF-754853F0E810 Q27348347-D859B5EE-2864-4C40-8B89-3784AFE8AC69 Q33601748-F03EEF92-B020-4DD0-A9E1-262BD69B9863 Q34073788-AED68949-DFFA-494D-A884-9DD73479A94F Q34299797-D9030E44-5D22-46D8-A78E-C02E8EE898A1 Q34695953-5436A0F3-4110-435E-B1C2-D7F4096A5D62 Q35115872-EFA650F7-B45A-466D-89DF-EF66DED75ACC Q35325075-33CB190E-F05F-480F-B531-24942C9B75D1 Q35583991-29A9BF9E-F236-4425-B0FF-1B3543D8C1FC Q37135372-15B34CDC-1CBC-4D6D-9ADD-5A6F2446AF6B Q40254200-58B4AF82-F804-4A49-9F19-5FD2C9B5B319 Q42784235-F793CD3B-9E6D-4A9C-963A-CCE64533A2ED Q46634851-9CA48626-BE41-4C68-8DBC-A41F4AB2249B Q53270838-B5353148-399D-444A-821C-793221BDEC31 Q56984392-7E10D09C-0A2F-4F4F-8E00-53997E487B49 Q58919755-3A89DEEA-58D9-4B82-BDD0-17864CBA5F6E

P2860

Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.

http://www.wikidata.org/entity/Q48455124

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@en

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@nl

type

label

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@en

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@nl

prefLabel

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@en

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@nl

P1433

Q48455124-F8325B63-A919-4E9E-84A0-EB88119963A4

P1476

Q48455124-FF2F4F52-D7B9-42FF-8A5C-6ADF50C3FEDB

P2093

Q48455124-3F35BA67-CFBE-4FEC-9DE5-157E0CA464FE

Q48455124-559FE7F1-5823-4B1E-822D-6BCCD19B2B6D

Q48455124-642C93D3-7CCB-4B67-9F6B-50ACAA3897A6

Q48455124-688896AE-C2CE-4E88-9D0D-1CE61FB5484B

Q48455124-6896634F-E0ED-4CF9-9123-060E9A1ABA92

Q48455124-76A3F7DB-5BBE-4612-A0A8-DD03ECCD303F

Q48455124-C42A8AF3-59FA-4538-93B3-B09F0E2D281D

P2860

Q48455124-06DF7EE4-324E-4FC6-ADB2-A10E93F4AF9C

Q48455124-0D9FF29F-B209-407A-A794-30CB4575222B

Q48455124-1A99A62E-225F-4DFE-B376-A9778C79BF9E

Q48455124-2136AF74-995C-4B5B-94EA-FC8F0010CE9D

Q48455124-2C203015-473D-4A55-9C16-31A0A03E87E1

Q48455124-38564EA7-1445-440E-A93B-A5BBFB4A4CDA

Q48455124-54229064-8132-42A8-A6A1-B73CD75D312F

Q48455124-5BB24806-B262-4039-80B5-2AA56AEA5F09

Q48455124-604896F6-D778-4D9C-9860-4903C4F840A0

Q48455124-731CBCED-8049-4AA3-9163-3E929D7F4658

P304

Q48455124-908B9779-8FE0-4DDA-8ABD-9067857C1C35

P31

Q48455124-445A8308-B02F-42AB-8A4C-8E9B2D064BBB

P356

Q48455124-E8568849-ADD4-444C-BE5D-716ADC820D59

P407

Q48455124-EF8DC41C-0AC6-4E53-B046-365845FB3D78

P433

Q48455124-D89B50D0-000B-429C-96A9-963C6AE81ECB

P478

Q48455124-0B1C7015-BBBD-4C88-8B2C-89E985D4C6F9

P577

Q48455124-5A848681-48D9-47C3-8A1D-430075B9AC46

P698

Q48455124-A485E889-A932-40E6-BDEA-427DB289DF05

P921

Q48455124-4456F1EA-4F24-488D-BA37-E77104F40159

Q48455124-EA32F33F-CD1B-4783-85A9-9987BF4349E5

P356

JAPPLPHYSIOL.00239.2007

P1433

Journal of Applied Physiology

P1476

Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.

@en

P2093

Chris L Allen

http://www.w3.org/2001/XMLSchema#string

David E Nethery

http://www.w3.org/2001/XMLSchema#string

Elizabeth F O Kern

http://www.w3.org/2001/XMLSchema#string

Frank J Jacono

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Kern

http://www.w3.org/2001/XMLSchema#string

Jihane A Faress

http://www.w3.org/2001/XMLSchema#string

Rosana Eisenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Segregation of receptor and ligand regulates activation of epithelial growth factor receptor

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors

Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects

Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice.

Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice

Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Interstitial lung disease in lung cancer: separating disease progression from treatment effects.

P304

2077-2083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/JAPPLPHYSIOL.00239.2007

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17916677

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis